A phase II trial of FUdR in patients with advanced pancreatic cancer

AbstractPurpose   This phase II study was conducted to assess the efficacy of fluorodeoxyuridine (FUdR) in patients with metastatic, advanced pancreatic cancer who had no previous chemotherapy.